4′-O-substitutions determine selectivity of aminoglycoside antibiotics
Citations Over TimeTop 10% of 2014 papers
Abstract
Clinical use of 2-deoxystreptamine aminoglycoside antibiotics, which target the bacterial ribosome, is compromised by adverse effects related to limited drug selectivity. Here we present a series of 4',6'-O-acetal and 4'-O-ether modifications on glucopyranosyl ring I of aminoglycosides. Chemical modifications were guided by measuring interactions between the compounds synthesized and ribosomes harbouring single point mutations in the drug-binding site, resulting in aminoglycosides that interact poorly with the drug-binding pocket of eukaryotic mitochondrial or cytosolic ribosomes. Yet, these compounds largely retain their inhibitory activity for bacterial ribosomes and show antibacterial activity. Our data indicate that 4'-O-substituted aminoglycosides possess increased selectivity towards bacterial ribosomes and little activity for any of the human drug-binding pockets.
Related Papers
- → Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’(2017)90 cited
- The influence of aminoglycoside antibiotics on the in vitro function of rat liver ribosomes.(1984)
- → 784 EFFECTS OF CONCURRENT ANTIBIOTICS ON PAIN MEDICATION REQUIREMENTS(1985)
- Study on effect of aminoglycoside antibiotics against mycobacteria(2007)
- New Opportunities of Aminoglycoside Antibiotics Application(2014)